Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Obesity escalates Alzheimer’s disease and cancer via excess phosphatidylethanolamine-driven membrane remodeling

ABSTRACT: Obesity escalates Alzheimer’s disease and cancer via excess phosphatidylethanolamine-driven membrane remodeling

PROVIDER: PRJNA1178660 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR31140173_1.fastq.gz	Fastqsanger.gz
	SRR31140173_2.fastq.gz	Fastqsanger.gz
	SRR31140174_1.fastq.gz	Fastqsanger.gz
	SRR31140174_2.fastq.gz	Fastqsanger.gz
	SRR31140175_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

Obesity-driven phosphatidylethanolamine dysregulation impairs neuroimmune crosstalk and accelerates Alzheimer's pathogenesis

Project description:The paradox of Alzheimer’s disease (AD) and cancer refers to the asynchronism of the two diseases. Understanding the correlation between cancer and AD could enhance research efficiency by consolidating efforts, lead to broader therapeutic impacts through drugs targeting shared mechanisms. Obesity is believed to synchronize this dichotomy by coordinating the onset and progression of both AD and cancer, although the precise mechanism remains unclear. In this study, leveraging integrated multi-modality data, including lipidomics, proteomics, bulk and single-cell RNA transcriptomics, drug repositioning and subcellular visualization, we identified that an overabundance of phosphatidylethanolamine (PEhigh) flux from white adipose tissue in obese individuals underlies this agonist role, driving lipid droplet accumulation and disrupting lipid homeostasis. PEhigh flux escalates both cancer and AD by potentiating immune evasion in tumor models and facilitating amyloidosis and tauopathies in AD models, while restoring PE homeostasis in the brain alleviates cognitive impairment. Mechanistically, our validation demonstrates that PEhigh flux induces autophagic, immunological, and membrane remodeling processes, driving T-cell and microglia dysfunction, spatiotemporal disruption of intracellular signaling, and destabilization of critical membrane structures. The potentially convergent mechanisms and divergent details of PE across AD and cancer highlight its multifaceted implications and the druggability of the associated signaling pathways.

2024-11-08 | GSE280474 | GEO

Microbial infection instigates tau-related pathology in Alzheimer's disease via activating neuroimmune cGAS-STING pathway

Project description:Microbial infection, the strong trigger to directly induce inflammation in brain, is long considered a risk factor of Alzheimer's disease (AD), but how these infections contribute to neurodegeneration remains underexplored. To examine the effect of herpes simplex virus type 1 (HSV-1) infection on tauopathy in local hippocampus of P301S mice, we utilized a modified HSV-1 strain (mHSV-1) potentially relevant to AD, we found that its infection promotes tau-related pathology in part via activating neuroimmune cGAS-STING pathway in the tau mouse model. Specifically, Sting ablation causes the detectable improvement of neuronal dysfunction and loss in P301S mice, which is causally linked to lowered proinflammatory status in the brain. Administration of STING inhibitor H-151 alleviates neuroinflammation and tau-related pathology in P301S mice. These results jointly suggest that herpesviral infection, as the vital environmental risk factor, could induce tau-related pathology in AD pathogenesis partially via neuroinflammatory cGAS-STING pathway.

2024-04-11 | GSE229411 | GEO

Microbial infection instigates tau-related pathology in Alzheimer's disease via activating neuroimmune cGAS-STING pathway

2025-04-17 | GSE264504 | GEO

Microbial infection instigates tau-related pathology in Alzheimer's disease via activating neuroimmune cGAS-STING pathway

Project description:Microbial infection instigates tau-related pathology in Alzheimer's disease via activating neuroimmune cGAS-STING pathway

| PRJNA1102867 | ENA

Microbial infection instigates tau-related pathology in Alzheimer's disease via activating neuroimmune cGAS-STING pathway

Project description:Microbial infection instigates tau-related pathology in Alzheimer's disease via activating neuroimmune cGAS-STING pathway

| PRJNA954379 | ENA

Vagus nerve-mediated neuroimmune modulation accelerates remyelination and functional recovery in a preclinical model of multiple sclerosis

Project description:Failure of remyelination contributes to persistent disability in multiple sclerosis (MS), yet no approved therapies directly promote central nervous system repair. Observations of enhanced oligodendrocyte maturation signatures during vagus nerve-mediated neuroimmune modulation (VNIM) in the experimental autoimmune encephalomyelitis model of MS prompted us to test whether VNIM could promote remyelination. Here we show that VNIM, delivered as a single 1-minute treatment using clinically relevant parameters, accelerates remyelination and functional recovery in lysolecithin-induced focal demyelination. VNIM reduced lesion volume, increased remyelinated axons with thicker myelin sheaths, enhanced debris clearance, and promoted blood-brain barrier repair. Single-cell transcriptomic analyses revealed that VNIM reshaped the lesion microenvironment by promoting microglial states associated with debris clearance and pro-repair signaling while advancing oligodendrocyte precursor maturation. Together, these findings identify VNIM as a therapeutic strategy that coordinates glial repair programs to accelerate remyelination, providing preclinical rationale for an ongoing clinical trial in relapsing-remitting MS (ClinicalTrials.gov: NCT06796504). This GEO submission includes single-cell RNA sequencing (scRNA-seq) data from lesion, non-lesion, and naïve spinal cord white matter tissue used in this study.

2026-03-18 | GSE325248 | GEO

Vagus nerve-mediated neuroimmune modulation accelerates remyelination and functional recovery in a preclinical model of multiple sclerosis

Project description:Vagus nerve-mediated neuroimmune modulation accelerates remyelination and functional recovery in a preclinical model of multiple sclerosis

| PRJNA1439270 | ENA

Cerebellum Alzheimer's Disease

Project description:Ion channel splice array data from cerebellum brain tissue samples collected from Alzheimer's disease patients. Temporal cortex (Alzheimer's disease affected brain tissue structure) and cerebellum (Alzheimer's disease unaffected brain tissue structure) samples from control subjects were compared to temporal cortex and cerebellum of patients with Alzheimer's disease.

2010-06-11 | E-GEOD-6777 | biostudies-arrayexpress

Temporal Cortex Alzheimer's Disease

Project description:Ion channel splice array data from temporal cortex brain tissue samples collected from Alzheimer's disease patients. Temporal cortex (Alzheimer's disease affected brain tissue structure) and cerebellum (Alzheimer's disease unaffected brain tissue structure) samples from control subjects were compared to temporal cortex and cerebellum of patients with Alzheimer's disease.

2010-06-11 | E-GEOD-6775 | biostudies-arrayexpress

Cerebellum Control (Alzheimer's disease control)

Project description:Ion channel splice array data from cerebellum brain tissue samples collected from control (non Alzheimer's disease) subjects. Temporal cortex (Alzheimer's disease affected brain tissue structure) and cerebellum (Alzheimer's disease unaffected brain tissue structure) samples from control subjects were compared to temporal cortex and cerebellum of patients with Alzheimer's disease.

2010-06-11 | E-GEOD-6778 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data